Skip to content
PICO Portalanswers from OpenAlex

Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants

PaperCitations, authors & open-access status

Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants is a paper indexed in PICO Portal from OpenAlex.

How many citations does Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants have?

PICO Portalcitation count

Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants has 67 citations in the OpenAlex counts PICO Portal stores.

When was Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants published?

PICO Portalyear

Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants has 2018 year in the PICO Portal index.

What is the open-access status of Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants?

PICO Portaloa status

Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants has closed oa status in the PICO Portal index.

What is the DOI of Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants?

PICO Portaldoi

The DOI for Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants is on the source record.

What is the PMID of Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants?

PICO Portalpmid

The PMID for Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants is on the source record.

What is the OpenAlex record for Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants?

PICO Portalopenalex

The OpenAlex for Response to crizotinib in advanced ALK -rearranged non-small cell lung cancers with different ALK -fusion variants is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial